Current strategies for the management of neonatal urea cycle disorders
- PMID: 11148547
- DOI: 10.1067/mpd.2001.111834
Current strategies for the management of neonatal urea cycle disorders
Abstract
The treatment of newborns with urea cycle disorders has evolved over the years into a complex multidisciplinary effort. The complexity derives from the number of issues that must be addressed simultaneously. At the Urea Cycle Disorders Consensus Meeting held in Washington, D.C., a panel of physicians and other professionals with extensive experience in this field was assembled to bring some systematization to this task. This manuscript is a condensation of the collective opinion and experience of that group. The outcome of untreated or poorly treated patients with urea cycle disorders is universally bad. Although a favorable outcome is not always feasible, even with the best therapy, the methods outlined here should help treat such a patient by drawing on the experience of others who have treated patients with urea cycle disorders. This article does not purport to be the final word in treating children with these disorders. However, by establishing some common ground, new methods can be tried and compared with existing ones. In a future that holds the prospect of gene therapy "cures" for these diseases, striving for the best possible outcome in the critical newborn period is a worthy goal.
Similar articles
-
Urea cycle disorders.Clin Liver Dis. 2000 Nov;4(4):815-30, vi. doi: 10.1016/s1089-3261(05)70143-4. Clin Liver Dis. 2000. PMID: 11232359 Review.
-
Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.N Engl J Med. 2007 May 31;356(22):2282-92. doi: 10.1056/NEJMoa066596. N Engl J Med. 2007. PMID: 17538087 Clinical Trial.
-
[Hyperammonemia type II as an example of urea cycle disorder].Wiad Lek. 2006;59(7-8):512-5. Wiad Lek. 2006. PMID: 17209350 Review. Polish.
-
Alternative pathway therapy for urea cycle disorders: twenty years later.J Pediatr. 2001 Jan;138(1 Suppl):S46-54; discussion S54-5. doi: 10.1067/mpd.2001.111836. J Pediatr. 2001. PMID: 11148549 Review.
-
Proceedings of a consensus conference for the management of patients with urea cycle disorders.J Pediatr. 2001 Jan;138(1 Suppl):S6-10. doi: 10.1067/mpd.2001.111831. J Pediatr. 2001. PMID: 11148544 Review.
Cited by
-
Rapid resolution of hyperammonemia in neonates using extracorporeal membrane oxygenation as a platform to drive hemodialysis.J Perinatol. 2018 Jun;38(6):665-671. doi: 10.1038/s41372-018-0084-0. Epub 2018 Feb 21. J Perinatol. 2018. PMID: 29467521 Free PMC article.
-
Dialysis and pediatric acute kidney injury: choice of renal support modality.Pediatr Nephrol. 2009 Jan;24(1):37-48. doi: 10.1007/s00467-008-0826-x. Epub 2008 May 16. Pediatr Nephrol. 2009. PMID: 18483748 Free PMC article. Review.
-
Renal replacement therapy in neonates with an inborn error of metabolism.Korean J Pediatr. 2019 Feb;62(2):43-47. doi: 10.3345/kjp.2018.07143. Epub 2018 Nov 7. Korean J Pediatr. 2019. PMID: 30404428 Free PMC article.
-
Ornithine transcarbamylase deficiency that developed at the age of 19 years with acute brain edema.Acute Med Surg. 2016 May 13;3(4):419-423. doi: 10.1002/ams2.214. eCollection 2016 Oct. Acute Med Surg. 2016. PMID: 29123827 Free PMC article.
-
Chemotherapy in a Breast Cancer Patient Heterozygous Carrier of Ornithine Transcarbamylase Deficiency.Cureus. 2020 May 26;12(5):e8301. doi: 10.7759/cureus.8301. Cureus. 2020. PMID: 32601573 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
